Device Coverage Policies Under Federal Employee Health Plans Questioned
This article was originally published in The Gray Sheet
Executive Summary
FDA-approved devices and drugs should not be considered "investigational" by health plans participating in the Federal Employee Health Benefits Program, Reps. Joe Barton (R-Tex.) and Anna Eshoo (D-Calif.) say in a recent letter to Office of Personnel Management Director Janice Lachance.